BACKGROUND/AIMS: The role of acid and duodeno-gastro-esophageal reflux (DGE
R), also termed bile reflux, in esophageal mucosal injury is controversial.
Several recent developments, especially availability of the recent bilirub
in monitoring device (Bilitec), have resulted in clarifications in this are
a. In order to better understand the role of acid and DGER in esophageal mu
cosal injury, we summarized the recent pulibcations in this area.
METHODOLOGY: Review of published medical literature (MEDLINE) on the clinic
al consequence of esophageal exposure to gastric acid or DGER.
RESULTS: Recent data suggest that esophageal pH monitoring and pH >7 is a p
oor marker for reflux of duodenal contents into the esophagus. DGER in non-
acidic environments (i.e., partial gastrectomy patients) may cause symptoms
but does not cause esophageal mucosal injury. Acid and duodenal contents u
sually reflux into the esophagus simultaneously, and may be contributing to
the development of Barrett's metaplasia and possibly adenocarcinoma. Proto
n pump inhibitors decrease acid and DGER by reducing intragastric volume av
ailable for reflux and raising intragastric pH. The promotility agent cisap
ride decreases DGER by increasing LES pressure and improving gastric emptyi
ng.
CONCLUSIONS: 1) The term "alkaline reflux" is a misnormer and should no lon
ger be used in referring to reflux of duodenal contents. 2) Bilitec is the
method of choice in detecting DGER and should always be used simultaneously
with esophageal pH-monitoring for acid reflux. 3) DGER alone is not injuri
ous to esophageal mucosa, but can result in significant esophageal mucosal
injury when combined with acid reflux. 4) Therefore, controlling esophageal
exposure to acid reflux by using proton pump inhibitors also eliminates th
e potentially damaging effect of DGER.